Stago Group News

Albio is to join Stago, global IVD Haemostasis leader

The Stago Group, the world leader in Haemostasis and Thrombosis, has recently acquired Albio with the aim of developing its direct sales in Turkey.

Read more

STA-Liatest D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA-Liatest D-Di for the exclusion of the diagnosis of Deep Vein Thrombosis (DVT) on data reported from the multi-national, DiET study. Exclusion of the diagnosis of Pulmonary embolism (PE) was previously 510(k) cleared in 2014.

Read more

New publication confirms efficacy and excellent performances of STA-Liatest D-Di for excluding Pulmonary Embolism

Results of the DiET Study have been recently published in Blood coagulation fibrinolysis, July 2016.

Read more

Stago’s “Practical Manual” collection - volume 3 has arrived!

The Practical Manual collection, a series of practical/scientific booklets in English, launched 3 years ago by Stago, has grown! This year being the centenary of the discovery of heparin, volume 3 is naturally devoted to parenteral anticoagulants.

Read more

Stago Scientific Meeting (November 19, 2014)

This symposium has been a great opportunity for Stago to invite key customers from all new affiliates in Europe. Around 90 customers joined us in Enghien-les-Bains a famous spa resort and a well-to-do suburb of Paris for sharing scientific sessions as well as the launch of a new analyser of the Max Generation, the STA R Max.

Read more